Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer

International Braz J Urol

Volumn 35, Issue 1, 2009, Pages 43-48

  Seabra, Daniel ^a   Faria, Eliney ^a   Dauster, Breno ^a   Rodrigues, Gunther ^a   Fava, Gilberto ^a  

^a Fundacao Pio XII   (Brazil)

Author keywords

Prostate cancer; Prostatectomy; Radiotherapy; Salvage therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; CANCER STAGING; ERECTILE DYSFUNCTION; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; PROSTATECTOMY; RADIATION DOSE; RADIATION RESPONSE; SALVAGE THERAPY; TREATMENT OUTCOME; TUMOR RECURRENCE; URINE INCONTINENCE;

AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION TOLERANCE; SALVAGE THERAPY; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 67649628235     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382009000100007     Document Type: Article

References (19)

1. Estimativa 2008: incidência de câncer no Brasil. Rio de Janeiro, INCA. 2007; pp. 33-4. Disponível em: http://www.inca.gov.br/estimativa/2008/versaofinal.pdf.
2. Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, et al.: Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol. 2006; 176: 2025-31; discussion 2031-2.
3. Mador DR, Huben RP, Wajsman Z, Pontes JE: Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate. J Urol. 1985; 133: 58-60.
4. Ward JF, Sebo TJ, Blute ML, Zincke H: Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol. 2005; 173: 1156-60.
5. Dall'Oglio MF, Barreto F, Paranhos M, Nesrallah A, Nesrallah L, Srougi M: Salvage radical prostatectomy: an alternative treatment for local recurrence of radioresistant cancer. Int Braz J Urol. 2006; 32: 550-6.
6. Huang WC, Kuroiwa K, Serio AM, Bianco FJ Jr, Fine SW, Shayegan B, et al.: The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol. 2007; 177: 1324-9.
7. Berry DL, Ellis WJ, Woods NF, Schwien C, Mullen KH, Yang C: Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol. 2003; 21: 93-100.
8. Touma NJ, Izawa JI, Chin JL: Current status of local salvage therapies following radiation failure for prostate cancer. J Urol. 2005; 173: 373-9.
9. Zelefsky MJ, Fuks Z, Leibel SA: Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol. 2002; 12: 229-37.
10. Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M: Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys. 2000; 48: 355-67.
11. Zietman AL, Tibbs MK, Dallow KC, Smith CT, Althausen AF, Zlotecki RA, et al.: Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate. Radiother Oncol. 1996; 40: 159-62.
12. Sartor CI, Strawderman MH, Lin XH, Kish KE, McLaughlin PW, Sandler HM: Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 1997; 38: 941-7.
13. Lee WR, Hanks GE, Hanlon A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol. 1997; 15: 230-8.
14. Lee AK, D'Amico AV: Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy. J Clin Oncol. 2005; 23: 8192-7.
15. [No authors listed] Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997; 37: 1035-41.
16. Stephenson AJ, Eastham JA: Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol. 2005; 23: 8198-203.
17. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC: Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999; 281: 1591-7.
18. Vaidya A, Soloway MS: Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. J Urol. 2000; 164: 1998-2001.
19. Vallancien G, Gupta R, Cathelineau X, Baumert H, Rozet F: Initial results of salvage laparoscopic radical prostatectomy after radiation failure. J Urol. 2003; 170: 1838-40.